pet care
Stifel Outmaneuvers Morgan vs. Sluggish Benchmark for Pet Health
Stifel’s $32 price target for Elanco lines up with a more optimistic view of pet-health growth than most analysts, but the gap raises questions about whether newcomers should follow the bullish call. Stifel’s $32 target implies roughly 31% upside from the current share price. Medical Disclaimer: This article